Clinical spectrum and risk of PHACE syndrome in cutaneous and airway hemangiomas

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 7, 2011, Pages 680-687

  Haggstrom, Anita N ^a   Skillman, Sarah ^a   Garzon, Maria C ^b   Drolet, Beth A ^c   Holland, Kristen ^c   Matt, Bruce ^a   McCuaig, Catherine ^d   Metry, Denise W ^e   Morel, Kimberly ^b   Powell, Julie ^d   Frieden, Ilona J ^f  

^a INDIANA UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF MONTREAL   (Canada)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PREDNISOLONE; PROPRANOLOL; STEROID; VINCRISTINE;

AIRWAY HEMANGIOMA; ARTICLE; BRAIN MALFORMATION; CHIN; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; DISEASE COURSE; EYE MALFORMATION; FATALITY; FEMALE; GLOTTIS; HEMANGIOMA; HUMAN; INFANT; LIP; MALE; MANDIBLE; PHACE SYNDROME; RISK ASSESSMENT; SKIN HEMANGIOMA; SYMPTOM;

ABNORMALITIES, MULTIPLE; BRONCHOSCOPY; DIAGNOSIS, DIFFERENTIAL; EYE ABNORMALITIES; FACIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEUROCUTANEOUS SYNDROMES; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY TRACT NEOPLASMS; SKIN NEOPLASMS; SYNDROME;

EID: 79960490804     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2011.113     Document Type: Article

References (18)

1. Shikhani airway hemangioma, Jones MM, Marsh BR, Holliday MJ. Infantile subglottic hemangiomas: an update. Ann Otol Rhinol Laryngol. 1986;95(4, pt 1): 336-347.
2. Bitar MA, Moukarbel RV, Zalzal GH. Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol Head Neck Surg. 2005;132(2):226-231. (Pubitemid 40431135)
3. Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J Pediatr. 1997;131(4):643-646.
4. Metry D, Heyer G, Hess C, et al; PHACE Syndrome Research Conference. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics. 2009; 124(5):1447-1456.
5. Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics. 2010;126(2):e418-e426.
6. Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics. 2006;117(3):698-703. (Pubitemid 46063211)
7. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions: proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol. 2005; 22(5):383-406.
8. Suh KY, Rosbe KW, Meyer AK, Frieden IJ. Extensive airway hemangiomas in two patients without beard hemangiomas. Pediatr Dermatol. 2010.
9. Badi AN, Kerschner JE, North PE, Drolet BA, Messner A, Perkins JA. Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Int J Pediatr Otorhinolaryngol. 2009;73(9):1187-1191.
10. Sherrington CA, Sim DK, Freezer NJ, Robertson CF. Subglottic haemangioma. Arch Dis Child. 1997;76(5):458-459. (Pubitemid 27261868)
11. Mulliken JB, Marler JJ, Burrows PE, Kozakewich HP. Reticular infantile hemangioma of the limb can be associated with ventral-caudal anomalies, refractory ulceration, and cardiac overload. Pediatr Dermatol. 2007;24(4):356-362. (Pubitemid 47382862)
12. Chang LC, Haggstrom AN, Drolet BA, et al; Hemangioma Investigator Group. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008;122(2):360-367.
13. Rudnick EF, Chen EY, Manning SC, Perkins JA. PHACES syndrome: otolaryngic considerations in recognition and management. Int J Pediatr Otorhinolaryngol. 2009;73(2):281-288.
14. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31(1): 11-22. (Pubitemid 30054381)
15. Pransky SM, Canto C. Management of subglottic hemangioma. Curr Opin Otolaryngol Head Neck Surg. 2004;12(6):509-512. (Pubitemid 39565206)
16. Rahbar R, Nicollas R, Roger G, et al. The biology and management of subglottic hemangioma: past, present, future. Laryngoscope. 2004;114(11):1880- 1891. (Pubitemid 39539842)
17. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol. 2009;73(8):1168-1172.
18. O-Lee TJ, Messner A. Subglottic hemangioma. Otolaryngol Clin North Am. 2008; 41(5):903-911, viii-ix.